List of Tables
Table 1. Global Oncology and Cancer Treatment Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oncology and Cancer Treatment Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oncology and Cancer Treatment Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oncology and Cancer Treatment Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oncology and Cancer Treatment Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oncology and Cancer Treatment Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oncology and Cancer Treatment Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oncology and Cancer Treatment Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oncology and Cancer Treatment Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oncology and Cancer Treatment Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oncology and Cancer Treatment Drug, Product Type & Application
Table 12. Global Key Manufacturers of Oncology and Cancer Treatment Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oncology and Cancer Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology and Cancer Treatment Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncology and Cancer Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oncology and Cancer Treatment Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Oncology and Cancer Treatment Drug Sales Market Share by Region (2020-2025)
Table 19. Global Oncology and Cancer Treatment Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Oncology and Cancer Treatment Drug Sales Market Share by Region (2026-2031)
Table 21. Global Oncology and Cancer Treatment Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oncology and Cancer Treatment Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Oncology and Cancer Treatment Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oncology and Cancer Treatment Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Oncology and Cancer Treatment Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oncology and Cancer Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Oncology and Cancer Treatment Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Oncology and Cancer Treatment Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oncology and Cancer Treatment Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oncology and Cancer Treatment Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oncology and Cancer Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oncology and Cancer Treatment Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oncology and Cancer Treatment Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oncology and Cancer Treatment Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oncology and Cancer Treatment Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oncology and Cancer Treatment Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oncology and Cancer Treatment Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oncology and Cancer Treatment Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oncology and Cancer Treatment Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oncology and Cancer Treatment Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oncology and Cancer Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oncology and Cancer Treatment Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oncology and Cancer Treatment Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oncology and Cancer Treatment Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oncology and Cancer Treatment Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oncology and Cancer Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oncology and Cancer Treatment Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oncology and Cancer Treatment Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oncology and Cancer Treatment Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oncology and Cancer Treatment Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Oncology and Cancer Treatment Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Oncology and Cancer Treatment Drug Sales Market Share by Type (2020-2025)
Table 53. Global Oncology and Cancer Treatment Drug Sales Market Share by Type (2026-2031)
Table 54. Global Oncology and Cancer Treatment Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oncology and Cancer Treatment Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oncology and Cancer Treatment Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Oncology and Cancer Treatment Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Oncology and Cancer Treatment Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Oncology and Cancer Treatment Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Oncology and Cancer Treatment Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Oncology and Cancer Treatment Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Oncology and Cancer Treatment Drug Sales Market Share by Application (2020-2025)
Table 63. Global Oncology and Cancer Treatment Drug Sales Market Share by Application (2026-2031)
Table 64. Global Oncology and Cancer Treatment Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oncology and Cancer Treatment Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oncology and Cancer Treatment Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Oncology and Cancer Treatment Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Oncology and Cancer Treatment Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Oncology and Cancer Treatment Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Oncology and Cancer Treatment Drug Product
Table 74. Roche Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Novartis Oncology and Cancer Treatment Drug Product
Table 79. Novartis Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Oncology and Cancer Treatment Drug Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Bayer Company Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Bayer Oncology and Cancer Treatment Drug Product
Table 89. Bayer Recent Developments/Updates
Table 90. Merck & Co Company Information
Table 91. Merck & Co Description and Business Overview
Table 92. Merck & Co Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Merck & Co Oncology and Cancer Treatment Drug Product
Table 94. Merck & Co Recent Developments/Updates
Table 95. Eli Lilly Company Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Eli Lilly Oncology and Cancer Treatment Drug Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Pfizer Oncology and Cancer Treatment Drug Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Johnson & Johnson Company Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Johnson & Johnson Oncology and Cancer Treatment Drug Product
Table 109. Johnson & Johnson Recent Developments/Updates
Table 110. Astellas Company Information
Table 111. Astellas Description and Business Overview
Table 112. Astellas Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Astellas Oncology and Cancer Treatment Drug Product
Table 114. Astellas Recent Developments/Updates
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. AbbVie Oncology and Cancer Treatment Drug Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Teva Company Information
Table 121. Teva Description and Business Overview
Table 122. Teva Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Teva Oncology and Cancer Treatment Drug Product
Table 124. Teva Recent Developments/Updates
Table 125. Otsuka Company Information
Table 126. Otsuka Description and Business Overview
Table 127. Otsuka Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Otsuka Oncology and Cancer Treatment Drug Product
Table 129. Otsuka Recent Developments/Updates
Table 130. Amgen Company Information
Table 131. Amgen Description and Business Overview
Table 132. Amgen Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Amgen Oncology and Cancer Treatment Drug Product
Table 134. Amgen Recent Developments/Updates
Table 135. Yi Bai Pharmaceutical Company Information
Table 136. Yi Bai Pharmaceutical Description and Business Overview
Table 137. Yi Bai Pharmaceutical Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Yi Bai Pharmaceutical Oncology and Cancer Treatment Drug Product
Table 139. Yi Bai Pharmaceutical Recent Developments/Updates
Table 140. Qilu Pharmaceutical Company Information
Table 141. Qilu Pharmaceutical Description and Business Overview
Table 142. Qilu Pharmaceutical Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Qilu Pharmaceutical Oncology and Cancer Treatment Drug Product
Table 144. Qilu Pharmaceutical Recent Developments/Updates
Table 145. Sun Pharma Company Information
Table 146. Sun Pharma Description and Business Overview
Table 147. Sun Pharma Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Sun Pharma Oncology and Cancer Treatment Drug Product
Table 149. Sun Pharma Recent Developments/Updates
Table 150. Accord Healthcare Company Information
Table 151. Accord Healthcare Description and Business Overview
Table 152. Accord Healthcare Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Accord Healthcare Oncology and Cancer Treatment Drug Product
Table 154. Accord Healthcare Recent Developments/Updates
Table 155. SK Chemicals Company Information
Table 156. SK Chemicals Description and Business Overview
Table 157. SK Chemicals Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. SK Chemicals Oncology and Cancer Treatment Drug Product
Table 159. SK Chemicals Recent Developments/Updates
Table 160. Bristol-Myers Squibb Company Information
Table 161. Bristol-Myers Squibb Description and Business Overview
Table 162. Bristol-Myers Squibb Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Bristol-Myers Squibb Oncology and Cancer Treatment Drug Product
Table 164. Bristol-Myers Squibb Recent Developments/Updates
Table 165. Takeda Company Information
Table 166. Takeda Description and Business Overview
Table 167. Takeda Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Takeda Oncology and Cancer Treatment Drug Product
Table 169. Takeda Recent Developments/Updates
Table 170. Eisai Company Information
Table 171. Eisai Description and Business Overview
Table 172. Eisai Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Eisai Oncology and Cancer Treatment Drug Product
Table 174. Eisai Recent Developments/Updates
Table 175. Biogen Idec Company Information
Table 176. Biogen Idec Description and Business Overview
Table 177. Biogen Idec Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Biogen Idec Oncology and Cancer Treatment Drug Product
Table 179. Biogen Idec Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Oncology and Cancer Treatment Drug Distributors List
Table 183. Oncology and Cancer Treatment Drug Customers List
Table 184. Oncology and Cancer Treatment Drug Market Trends
Table 185. Oncology and Cancer Treatment Drug Market Drivers
Table 186. Oncology and Cancer Treatment Drug Market Challenges
Table 187. Oncology and Cancer Treatment Drug Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oncology and Cancer Treatment Drug
Figure 2. Global Oncology and Cancer Treatment Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncology and Cancer Treatment Drug Market Share by Type: 2024 & 2031
Figure 4. Chemotherapy Drug Product Picture
Figure 5. Targeted Drug Product Picture
Figure 6. Immunotherapy Drug Product Picture
Figure 7. Global Oncology and Cancer Treatment Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Oncology and Cancer Treatment Drug Market Share by Application: 2024 & 2031
Figure 9. Benign Tumor
Figure 10. Cancer and Other Malignant Tumors
Figure 11. Global Oncology and Cancer Treatment Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Oncology and Cancer Treatment Drug Market Size (2020-2031) & (US$ Million)
Figure 13. Global Oncology and Cancer Treatment Drug Sales (2020-2031) & (K Units)
Figure 14. Global Oncology and Cancer Treatment Drug Average Price (US$/Unit) & (2020-2031)
Figure 15. Oncology and Cancer Treatment Drug Report Years Considered
Figure 16. Oncology and Cancer Treatment Drug Sales Share by Manufacturers in 2024
Figure 17. Global Oncology and Cancer Treatment Drug Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Oncology and Cancer Treatment Drug Players: Market Share by Revenue in Oncology and Cancer Treatment Drug in 2024
Figure 19. Oncology and Cancer Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Oncology and Cancer Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Oncology and Cancer Treatment Drug Sales Market Share by Country (2020-2031)
Figure 22. North America Oncology and Cancer Treatment Drug Revenue Market Share by Country (2020-2031)
Figure 23. United States Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Oncology and Cancer Treatment Drug Sales Market Share by Country (2020-2031)
Figure 26. Europe Oncology and Cancer Treatment Drug Revenue Market Share by Country (2020-2031)
Figure 27. Germany Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Oncology and Cancer Treatment Drug Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Oncology and Cancer Treatment Drug Revenue Market Share by Region (2020-2031)
Figure 34. China Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Oncology and Cancer Treatment Drug Sales Market Share by Country (2020-2031)
Figure 42. Latin America Oncology and Cancer Treatment Drug Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Oncology and Cancer Treatment Drug Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Oncology and Cancer Treatment Drug Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Oncology and Cancer Treatment Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Oncology and Cancer Treatment Drug by Type (2020-2031)
Figure 52. Global Revenue Market Share of Oncology and Cancer Treatment Drug by Type (2020-2031)
Figure 53. Global Oncology and Cancer Treatment Drug Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Oncology and Cancer Treatment Drug by Application (2020-2031)
Figure 55. Global Revenue Market Share of Oncology and Cancer Treatment Drug by Application (2020-2031)
Figure 56. Global Oncology and Cancer Treatment Drug Price (US$/Unit) by Application (2020-2031)
Figure 57. Oncology and Cancer Treatment Drug Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
